GSE164884 nicotinamide stem cell 2 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE164884_nicotinamide_stem cell_2_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE164884_nicotinamide_stem cell_2_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE164884_nicotinamide_stem cell_2_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE164884_nicotinamide_stem cell_2_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

G protein signaling modulator 3

Gene

Pvt1 oncogene

Gene

ZNFX1 antisense RNA 1

Gene

ATPase H+ transporting V1 subunit G2

Gene

long intergenic non-protein coding RNA 973

Gene

TRG antisense RNA 1

Gene

BST2 interferon stimulated positive regulator

Gene

uncharacterized LOC105377329

Gene

FOXD2 adjacent opposite strand RNA 1

Gene

cancer susceptibility 8

  • Gene

    G protein signaling modulator 3



  • Gene

    ZNFX1 antisense RNA 1


  • Gene

    ATPase H+ transporting V1 subunit G2


  • Gene

    long intergenic non-protein coding RNA 973


  • Gene

    TRG antisense RNA 1


  • Gene

    BST2 interferon stimulated positive regulator


  • Gene

    uncharacterized LOC105377329


  • Gene

    FOXD2 adjacent opposite strand RNA 1


  • Gene

    cancer susceptibility 8

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.